Synlogic, Inc. (SYBX) financial statements (2021 and earlier)
Company profile
| Business Address |
301 BINNEY STREET CAMBRIDGE, MA 02142 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | 6/30/2018 Q2 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments, including: | 120 | 120 | 129 | 110 | 123 | 133 | 143 | ||
| Cash and cash equivalents | 26 | 27 | 17 | 16 | 11 | 17 | 27 | ||
| Short-term investments | 93 | 93 | 112 | 94 | 111 | 115 | 117 | ||
| Other undisclosed cash, cash equivalents, and short-term investments | 0 | 0 | (0) | (0) | (0) | (0) | (0) | ||
| Receivables | 3 | 2 | |||||||
| Prepaid expense | 1 | 11 | 31 | 1 | |||||
| Other current assets | 1 | 1 | 3 | 0 | |||||
| Other undisclosed current assets | 12 | (0) | 0 | 1 | 0 | 1 | 2 | ||
| Total current assets: | 133 | 131 | 163 | 114 | 124 | 136 | 145 | ||
| Noncurrent Assets | |||||||||
| Finance lease, right-of-use asset | 1 | 1 | ✕ | ✕ | ✕ | ||||
| Operating lease, right-of-use asset | 17 | 18 | ✕ | ✕ | ✕ | ||||
| Property, plant and equipment | 13 | 13 | 14 | 14 | 15 | 15 | 15 | ||
| Long-term investments and receivables | 15 | 37 | 20 | ||||||
| Long-term investments | 15 | 37 | 20 | ||||||
| Restricted cash and investments | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||
| Other noncurrent assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Other undisclosed noncurrent assets | 8 | 1 | 17 | 16 | |||||
| Total noncurrent assets: | 55 | 71 | 52 | 31 | 16 | 16 | 16 | ||
| TOTAL ASSETS: | 189 | 202 | 215 | 145 | 140 | 152 | 161 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 6 | 6 | 7 | 6 | 7 | 8 | 8 | ||
| Accounts payable | 2 | 2 | 3 | 2 | 2 | 3 | 1 | ||
| Accrued liabilities | 4 | 4 | 4 | 4 | 5 | 4 | 7 | ||
| Deferred revenue | 1 | 2 | ✕ | ✕ | ✕ | ||||
| Debt | 2 | 2 | 0 | 0 | 0 | ||||
| Deferred rent credit | 0 | 0 | |||||||
| Contract with customer, liability | ✕ | ✕ | 2 | 2 | 0 | 0 | 0 | ||
| Other undisclosed current liabilities | 2 | 2 | |||||||
| Total current liabilities: | 9 | 10 | 11 | 10 | 8 | 9 | 8 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 23 | 23 | 0 | 0 | 0 | ||||
| Finance lease, liability | 0 | 0 | ✕ | ✕ | ✕ | ||||
| Capital lease obligations | ✕ | ✕ | ✕ | ✕ | 0 | 0 | 0 | ||
| Operating lease, liability | 23 | 23 | ✕ | ✕ | ✕ | ||||
| Liabilities, other than long-term debt | 0 | 8 | 8 | 8 | |||||
| Contract with customer, liability | ✕ | ✕ | ✕ | 0 | |||||
| Deferred rent credit | 8 | 8 | 8 | ||||||
| Other undisclosed noncurrent liabilities | 23 | 22 | |||||||
| Total noncurrent liabilities: | 23 | 23 | 23 | 23 | 8 | 8 | 8 | ||
| Total liabilities: | 32 | 34 | 34 | 33 | 16 | 17 | 16 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent | 157 | 169 | 181 | 112 | 124 | 135 | 145 | ||
| Common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Additional paid in capital | 328 | 327 | 326 | 245 | 244 | 243 | 242 | ||
| Accumulated other comprehensive income (loss) | 0 | 0 | 0 | 0 | (0) | (0) | (0) | ||
| Accumulated deficit | (171) | (158) | (145) | (133) | (120) | (108) | (97) | ||
| Total stockholders' equity: | 157 | 169 | 181 | 112 | 124 | 135 | 145 | ||
| TOTAL LIABILITIES AND EQUITY: | 189 | 202 | 215 | 145 | 140 | 152 | 161 | ||
Income statement (P&L) ($ in millions)
| 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | 6/30/2018 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Gross profit: | 1 | 0 | 0 | 0 | 0 | 2 | 0 | |
| Operating expenses | (15) | (14) | (13) | (14) | (13) | (13) | (16) | |
| Operating loss: | (13) | (14) | (13) | (14) | (13) | (12) | (15) | |
| Nonoperating income | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| Investment income, nonoperating | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| Interest and debt expense | (0) | (0) | (0) | (0) | (0) | (0) | (0) | |
| Loss from continuing operations before income taxes: | (13) | (13) | (12) | (13) | (12) | (11) | (15) | |
| Other undisclosed loss from continuing operations | (0) | |||||||
| Loss before gain (loss) on sale of properties: | (13) | (13) | (12) | (13) | (12) | (11) | (15) | |
| Other undisclosed net income | 0 | 0 | 0 | |||||
| Net loss: | (13) | (13) | (12) | (13) | (12) | (11) | (15) | |
| Other undisclosed net income attributable to parent | 0 | 0 | 0 | 0 | ||||
| Net loss available to common stockholders, diluted: | (13) | (13) | (12) | (13) | (12) | (11) | (15) | |
Comprehensive Income ($ in millions)
| 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | 6/30/2018 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (13) | (13) | (12) | (13) | (12) | (11) | (15) | |
| Comprehensive loss: | (13) | (13) | (12) | (13) | (12) | (11) | (15) | |
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (0) | 0 | 0 | 0 | (0) | 0 | 0 | |
| Comprehensive loss, net of tax, attributable to parent: | (13) | (13) | (12) | (13) | (12) | (11) | (15) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.